In CLL B cells from patients with aggressive disease, mutated NOTCH1 and TCL1 can act as DNA methylation inhibitors by interacting with DNMT3A at the protein level [2, 38]. This evidence concerns the gene DNMT3A and B-cell chronic lymphocytic leukemia.